DuchenneMuscularDystrophy,ifetroban,heart,DMD,Cardiomyopathy,ClinicalTrials,RareDisease,CardioX,Neurology

Mashup Score: 3

Significant Cardiac Benefit Seen With Ifetroban in Patients With Duchenne Muscular Dystrophy | Docwire News - 2 month(s) ago

Ifetroban shows significant 12-month cardiac benefit in DMD patients, per phase-2 FIGHT DMD trial results.

Source: www.docwirenews.com

Categories: General Medicine News, Partners & KOLs

Tweet Tweets with this article
- mydocwire
  
  🔥 Latest in #DuchenneMuscularDystrophy care: High-dose #ifetroban shows significant improvement in #heart function over 12 months, offering hope for #DMD patients. 🔗 Read more: https://t.co/1K3zyjMOsk #Cardiomyopathy #ClinicalTrials #RareDisease #CardioX #Neurology https://t.co/GG3Si7bTRL